Smith Group Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,180	Closed	-$134K	–	359
2019 Q4	$134K	Hold	2,180	–	–	0.01%	228
2019 Q3	$159K	Sell	2,180 -3,480	-61%	-$260K	0.01%	208
2019 Q2	$465K	Hold	5,660	–	–	0.02%	161
2019 Q1	$399K	Sell	5,660 -11,530	-67%	-$678K	0.01%	182
2018 Q4	$774K	Sell	17,190 -6,770	-28%	-$355K	0.03%	175
2018 Q3	$1.35M	Buy	23,960 +4,140	+21%	+$253K	0.04%	153
2018 Q2	$1.32M	Buy	19,820 +2,710	+16%	+$169K	0.04%	153
2018 Q1	$996K	Buy	+17,110	New	+$1.09M	0.03%	167
2016 Q4	–	Sell	-59,690	Closed	-$3.96M	–	451
2016 Q3	$3.96M	Sell	59,690 -30	-0.1%	-$1.88K	0.12%	100
2016 Q2	$3.33M	Buy	+59,720	New	+$2.9M	0.1%	105
2014 Q3	–	Sell	-1,020	Closed	-$35K	–	407
2014 Q2	$35K	Hold	1,020	–	–	﹤0.01%	287
2014 Q1	$32K	Buy	+1,020	New	+$27.1K	﹤0.01%	281